Positron emission tomography in the diagnosis of mesothelioma

Lung Cancer

Volumn 45, Issue SUPPL., 2004, Pages

  Haberkorn, Uwe ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CT; Diffuse pleural thickening; FDG PET imaging; Malignant pleural mesothelioma; MRI

Indexed keywords

ASBESTOS; FLUORODEOXYGLUCOSE; GLUCOSE;

ASBESTOSIS; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MESOTHELIOMA; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3142726198     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.04.016     Document Type: Conference Paper

References (13)

1. Ho L., Sugarbaker D.J., Skarin A.T. Malignant pleural mesothelioma. Cancer Treat. Res. 105:2001;327-373
2. Benard F., Sterman D., Smith R.J., Kaiser L.R., Albelda S.M., Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest. 114:1998;713-722
3. Yamamoto T., Seino Y., Fukumoto H., Koh G., Yano H., Inagaki N., et al. Over-expression of facilitative glucose transporter genes in human cancer. Biochem. Biophys. Res. Commun. 170:1990;223-230
4. Haberkorn U., Ziegler S.I., Oberdorfer F., Trojan H., Haag D., Peschke P., et al. FDG uptake tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl. Med. Biol. 21:1994;827-834
5. Carretta A., Landoni C., Melloni G., Ceresoli G.L., Compierchio A., Fazio F., et al. 18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study. Eur. J. Cardiothorac. Surg. 17:2000;377-383
6. Buchmann I., Guhlmann C.A., Elsner K., Gfrorer W., Schirrmeister H., Kotzerke J., et al. F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes. Nuklearmedizin. 38:1999;319-322
7. Schneider D.B., Clary-Macy C., Challa S., Sasse K.C., Merrick S.H., Hawkins R., et al. Positron emission tomography with F-18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 120:2000;128-133
8. 18F -FDG PET imaging for differentiating malignant from inflammatory processes J. Nucl. Med. 42:2001;1412-1417
9. Benard F., Sterman D., Smith R.J., Kaiser L.R., Albelda S.M., Alavi A. Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J. Nucl. Med. 40:1999;1241-1245
10. Haberkorn U., Strauss L.G., Dimitrakopoulou A., Seiffert E., Oberdorfer F., Ziegler S., et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J. Nucl. Med. 34:1993;12-17
11. Haberkorn U., Strauss L.G., Dimitrakopoulou A., Engenhart R., Oberdorfer F., Ostertag H., et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J. Nucl. Med. 32:1991;1485-1490
12. Haberkorn U., Bellemann M.E., Gerlach L., Morr I., Trojan H., Brix G., et al. Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase. Gene Ther. 5:1998;880-887
13. Marom E.M., Erasmus J.J., Pass H.I., Patz E.F. Jr. The role of imaging in malignant pleural mesothelioma. Semin. Oncol. 29:2002;26-35